Research Progress in SCLC Opens Doors to New Treatment Opportunities

Findings from a recent scientific study looking at a large number of small cell lung cancer (SCLC) patient specimens have the potential to change the way we diagnose and treat SCLC as well as the histological transformation, or conversion, of NSCLC into SCLC. Join Dr. Amy Moore, LUNGevity's VP, Global Engagement and Patient Partnerships, as she speaks with co-authors of the study -- Dr. Christine Lovly, a lung cancer researcher and physician at Vanderbilt University, and Dr. Smruthy Sivakumar, Senior Scientist in the Computational Discovery group (R&D) at Foundation Medicine -- to understand what these findings mean for patients.